Ultragenyx Pharmaceutical Inc.Ultragenyx Pharmaceutical Inc.Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc.

No trades
No trades

Fundamentals and stats

Top segments and regional performance

Last year, the company generated ‪673.00 M‬ USD, the most of which — ‪673.00 M‬ USD — came from its top-performing segment, Novel Products, compared to ‪560.23 M‬ USD the previous year. The greatest contribution came from North America, which accounted for ‪377.00 M‬ USD last year, with ‪340.46 M‬ USD the year before.

By source
By country